Search
Which chemotherapy drugs have the highest cardiotoxicity risk in pediatric cancer?
- OPACC
- Apr 16, 2019
- 1 min read
A recent study published in JAMA Oncology analyzed data generated from over 28,000 childhood cancer survivors and compared the lifetime cardiotoxicity risk in different chemotherapeutic drugs used for treatment.
Read more: https://www.medicalnewsbulletin.com/chemotherapy-drugs-highest-cardiotoxicity-risk-pediatric-cancer/
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...